PCOS Management with GLP-1 Agonists and Bioidentical Progesterone
Polycystic Ovary Syndrome (PCOS) is a complex condition, but advancements in treatment are providing new hope. At 23MD clinics in London and Dubai, we incorpora
Polycystic Ovary Syndrome (PCOS) is a complex condition, but advancements in treatment are providing new hope. At 23MD clinics in London and Dubai, we incorporate cutting-edge approaches for PCOS management with GLP-1 agonists and bioidentical progesterone therapy.
Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder.
PCOS affects approximately 10% of women of reproductive age globally.
- In the UK, PCOS affects around 10% of the female population (1 in 10 women)
- In the UAE, the incidence is even higher, with research indicating that up to 25% (1 in 4 women ) of women may be affected due to lifestyle and genetic factors.
Symptoms of PCOS
PCOS is characterised by insulin resistance, high androgen production, and progesterone resistance. This can cause a wide range on symptoms and long-term health risks including
- Acne
- Obesity
- Extra hair growth
- Irregular or heavy/painful periods
- Skin pigmentation
- Diabetes
- Endometrial hyperplasia including fibroids, polyps and womb cancer
Lifestyle Changes to Help with PCOS
Lifestyle changes like regular exercise, a balanced diet, and stress management remain key in managing PCOS. At 23MD, we guide our patients in London and Dubai through sustainable lifestyle changes that support overall well-being and improve insulin sensitivity.
Traditional Treatment Options
Before the introduction of GLP-1 agonists in PCOS management, traditional treatments like metformin, oral contraceptives, and anti-androgen medications were the norm. Insertion of the Progestin IUD like Mirena may also help control symptoms and reduce the estrogen dominence which can cause endometrial hyperplasia and womb cancer. These options are still vital, but at 23MD, we integrate newer therapies like GLP-1 agonists to enhance treatment outcomes for women with PCOS.
The Impact of GLP-1 Agonists in PCOS Management
GLP-1 agonists in PCOS management offer a breakthrough by addressing insulin resistance, promoting weight loss, and improving reproductive health simultaneously. Weight control and healthy BMI are crucial in controlling the symptoms and risks of PCOS. These medications are a vital part of our personalised treatment plans at 23MD, helping women in London and Dubai manage their PCOS symptoms more effectively.
Bioidentical Progesterone: Protecting Against Estrogen Dominance
Another critical development in PCOS management is the use of bioidentical progesterone to protect against estrogen dominance, which can lead to conditions like endometrial hyperplasia and womb cancer.
Estrogen dominence occurs because of multiple factors, including
- progesterone resistance
- an underproduction of progesterone
- an an over-production of estrogen.
Bioidentical progesterone balances estrogen levels, reducing the risk of these complications and ensuring overall hormonal health. Inserting a Progestin containing IUD like Mirena may also reduce the risk of endometrial hyperplasia and longer term womb cancer. At 23MD, we offer bio/bodyidentical hormone therapy tailored to individual needs, providing women with safer and more effective long-term management of PCOS.
Comprehensive PCOS Care at 23MD
At 23MD clinics in London and Dubai, our approach to PCOS management is holistic. We combine advanced therapies like GLP-1 agonists in PCOS management and bioidentical progesterone with lifestyle interventions and traditional treatments. By offering this comprehensive care, we help women regain control of their health and improve their quality of life.
If you’re struggling with PCOS, consider consulting with our expert team at 23MD in London or Dubai to explore these advanced treatment options.
For more detailed information , you can explore the following sources:
